[Cardiovascular disorders in patients infected with 2019 novel coronavirus]

V Aidan1, B Davido2, H Mustafic3

  • 1Département de cardiologie, centre de référence des cardiomyopathies et des troubles du rythme cardiaque héréditaires ou rares, hôpital Ambroise-Paré, université de Versailles-Saint Quentin (UVSQ), AP-HP, Boulogne-Billancourt, France.

Annales De Cardiologie Et D'Angeiologie
|March 1, 2021
PubMed

Insights

Coronavirus disease 2019 (COVID-19) frequently causes cardiovascular complications. This review examines cardiac issues and mortality predictors in COVID-19 patients, highlighting the need for integrated care.

Area of Science:

  • Cardiology
  • Infectious Diseases
  • Public Health

Background:

  • The COVID-19 pandemic presents a significant global health challenge.
  • Cardiovascular complications affect a substantial portion of COVID-19 patients, particularly those in intensive care.

Purpose of the Study:

  • To conduct a narrative review of cardiovascular complications in COVID-19 patients.
  • To identify predictive factors for mortality in individuals infected with SARS-CoV-2.

Main Methods:

  • Literature search for studies on COVID-19 and cardiovascular complications.
  • Narrative synthesis of findings regarding cardiac involvement and mortality predictors.

Main Results:

  • Cardiovascular complications are prevalent in COVID-19, occurring in 20% of all patients and 43% of ICU patients.
  • Multiple mechanisms contribute to cardiac injury, including hyperinflammation, pro-thrombotic states, sepsis, hypoxia, and direct viral insult.

Conclusions:

  • Cardiovascular complications are a major concern in COVID-19 management.
  • Understanding these complications and their predictive factors is crucial for improving patient outcomes and survival rates.

Related Concept Videos

Endocarditis II: Clinical Features of Infective Endocarditis01:25

Endocarditis II: Clinical Features of Infective Endocarditis

Endocarditis can present various clinical features depending on the causative organism and the patient's underlying health conditions. Initially, the clinical features of infective endocarditis develop gradually, presenting with nonspecific symptoms that can be easily mistaken for other illnesses.General SymptomsEarly symptoms of infective endocarditis are fever, chills, weakness, malaise, fatigue, and weight loss. These symptoms reflect the systemic nature of the infection and the body's...
143
Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
66
Cardiovascular Drugs: Classification based on Therapeutic Indications01:18

Cardiovascular Drugs: Classification based on Therapeutic Indications

Cardiovascular diseases, encompassing a range of conditions, can significantly affect the heart's operations and the overall circulatory system. These conditions impair the heart's ability to pump blood, leading to a deficit in oxygen supply to crucial organs. Anomalies in the heart's electrical system, known as arrhythmias, can cause heartbeats to accelerate or slow down. Usually, heart rates increase during physical activity and decrease while resting or sleeping. However,...
3.6K
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
146
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
129
Endocarditis III: Medical Management01:18

Endocarditis III: Medical Management

Infective endocarditis management involves a multifaceted approach encompassing infection prevention, lifestyle modifications, pharmacological therapy, and surgical management.Infection Prevention:Hand Hygiene: Thorough handwashing is crucial to prevent the spread of infection. Hand hygiene should be performed regularly, especially before and after using the restroom.Oral Hygiene: Good oral hygiene is essential. It includes brushing teeth immediately after waking up and before bed, flossing...
89